Oral Antidiabetic (OAD) Treatment Market Report

Global and China Oral Antidiabetic (OAD) Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 21, 2022
  • PAGES：178
  • REPORT CODE：GMM1482805
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oral Antidiabetic (OAD) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Mannkind

    • AstraZeneca

    • Eli Lilly

    • Pfizer

    • Merck

    • Sanofi

    • Novartis

    • Glenmark

    • Novo Nordisk

    • Boehringer Ingelheim

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Sulphonylureas

    • Biguanides

    • Intestinal -Glucosidase Inhibitors

    • Others

    Application:

    • Hospital

    • Clinics

    • Diabetics Treatment Centres

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Oral Antidiabetic (OAD) Treatment Industry Overview

      • 1.1.1 Oral Antidiabetic (OAD) Treatment Market Scope and Market Segments

      • 1.1.2 Oral Antidiabetic (OAD) Treatment Industry Characteristics

      • 1.1.3 Global and China Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Oral Antidiabetic (OAD) Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Sulphonylureas

      • 1.2.2 Biguanides

      • 1.2.3 Intestinal -Glucosidase Inhibitors

      • 1.2.4 Others

    • 1.3 Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinics

      • 1.3.3 Diabetics Treatment Centres

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Oral Antidiabetic (OAD) Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Oral Antidiabetic (OAD) Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Oral Antidiabetic (OAD) Treatment Industry PEST Analysis

    • 2.3 Oral Antidiabetic (OAD) Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Oral Antidiabetic (OAD) Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Oral Antidiabetic (OAD) Treatment Industry

    Chapter 3 Global and China Oral Antidiabetic (OAD) Treatment Market, by Manufacturer

    • 3.1 Global and China Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Oral Antidiabetic (OAD) Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Oral Antidiabetic (OAD) Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Oral Antidiabetic (OAD) Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Oral Antidiabetic (OAD) Treatment Market Top 3 Players

    Chapter 4 Global and China Oral Antidiabetic (OAD) Treatment Market, by Type (2017-2028)

    • 4.1 Oral Antidiabetic (OAD) Treatment Market Trend, by Type

    • 4.2 Global Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Oral Antidiabetic (OAD) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Oral Antidiabetic (OAD) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Oral Antidiabetic (OAD) Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Oral Antidiabetic (OAD) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Oral Antidiabetic (OAD) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Oral Antidiabetic (OAD) Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Oral Antidiabetic (OAD) Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Oral Antidiabetic (OAD) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Oral Antidiabetic (OAD) Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Oral Antidiabetic (OAD) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Oral Antidiabetic (OAD) Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Oral Antidiabetic (OAD) Treatment Market Analysis

    • 7.1 North America Oral Antidiabetic (OAD) Treatment Market, by Type

    • 7.2 North America Oral Antidiabetic (OAD) Treatment Market, by Application

    • 7.3 North America Oral Antidiabetic (OAD) Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Oral Antidiabetic (OAD) Treatment Market Analysis

    • 8.1 Europe Oral Antidiabetic (OAD) Treatment Market, by Type

    • 8.2 Europe Oral Antidiabetic (OAD) Treatment Market, by Application

    • 8.3 Europe Oral Antidiabetic (OAD) Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Oral Antidiabetic (OAD) Treatment Market Analysis

    • 9.1 APAC Oral Antidiabetic (OAD) Treatment Market, by Type

    • 9.2 APAC Oral Antidiabetic (OAD) Treatment Market, by Application

    • 9.3 APAC Oral Antidiabetic (OAD) Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Oral Antidiabetic (OAD) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Oral Antidiabetic (OAD) Treatment Company Profiles

      • 11.1 Mannkind

        • 11.1.1 Mannkind Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Mannkind Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.1.3 Mannkind Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 AstraZeneca

        • 11.2.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 AstraZeneca Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.2.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Eli Lilly

        • 11.3.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Eli Lilly Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.3.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer

        • 11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.4.3 Pfizer Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Merck

        • 11.5.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Merck Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.5.3 Merck Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sanofi

        • 11.6.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sanofi Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.6.3 Sanofi Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis

        • 11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Glenmark

        • 11.8.1 Glenmark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Glenmark Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.8.3 Glenmark Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Novo Nordisk

        • 11.9.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Novo Nordisk Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Boehringer Ingelheim

        • 11.10.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Product Profiles, Application and Specification

        • 11.10.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Oral Antidiabetic (OAD) Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Oral Antidiabetic (OAD) Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Oral Antidiabetic (OAD) Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Sulphonylureas (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Biguanides (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Intestinal -Glucosidase Inhibitors (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Diabetics Treatment Centres (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Oral Antidiabetic (OAD) Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Oral Antidiabetic (OAD) Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Oral Antidiabetic (OAD) Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Oral Antidiabetic (OAD) Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Oral Antidiabetic (OAD) Treatment Market Share, by Manufacturer in 2022

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Value, by Type (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Price Trend, by Type (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Value, by Type (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Price Trend, by Type (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Value, by Application (2017-2028)

    • Table Global Oral Antidiabetic (OAD) Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Oral Antidiabetic (OAD) Treatment Sales Value Share, by Application (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Value, by Application (2017-2028)

    • Table China Oral Antidiabetic (OAD) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table North America Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table North America Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Oral Antidiabetic (OAD) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Oral Antidiabetic (OAD) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Oral Antidiabetic (OAD) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Mannkind Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mannkind Product Profiles, Application and Specification

    • Table Mannkind Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Glenmark Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glenmark Product Profiles, Application and Specification

    • Table Glenmark Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US